PATENT CLAIM ANALYSIS

Application Number: 15934299
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["546", "133000"]

Abstract:
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g., HDAC2).

Claim (Index 4):
A method of treating a condition in a subject selected from a neurological disorder, memory or cognitive function disorder or impairment, disorder of learning extinction, fungal disease or infection, inflammatory disease, hematological disease, psychiatric disorders, and neoplastic disease, comprising administering to the subject in need thereof an effective amount the compound of  claim 1 .

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.21429
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15741609', '15867982', '14417477', '15321410', '15786134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7259764114684685
- 35 USC 102 Novelty (BERT): 0.5446365590334638
- Combined Prediction Score: 0.707842426224968
- Mean Citation Score: 306.012022
- Max Citation Score: 398.32266
- Similarity Product: 270.5006243485629

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test